![Foto de P. de la](/img/nophoto.png)
P. de la
Cueva Dobao
Publicacións nas que colabora con P. de la Cueva Dobao (9)
2023
-
Efficacy and Safety of Dimethyl Fumarate in Patients with Moderate-to-Severe Plaque Psoriasis: Results from a 52-Week Open-Label Phase IV Clinical Trial (DIMESKIN 1)
Dermatology and Therapy, Vol. 13, Núm. 1, pp. 329-345
2021
-
Food groups associated with immune-mediated inflammatory diseases: a Mendelian randomization and disease severity study
European Journal of Clinical Nutrition, Vol. 75, Núm. 9, pp. 1368-1382
-
Patient Journey in Atopic Dermatitis: The Real-World Scenario
Dermatology and Therapy, Vol. 11, Núm. 5, pp. 1693-1705
2019
-
Genetic variation at the glycosaminoglycan metabolism pathway contributes to the risk of psoriatic arthritis but not psoriasis
Annals of the Rheumatic Diseases, Vol. 78, Núm. 3, pp. 355-364
2016
-
Genome-Wide Pathway Analysis Identifies Genetic Pathways Associated with Psoriasis
Journal of Investigative Dermatology, Vol. 136, Núm. 3, pp. 593-602
-
Urine metabolome profiling of immune-mediated inflammatory diseases
BMC Medicine, Vol. 14, Núm. 1
2015
-
A deletion at adamts9-magi1 locus is associated with psoriatic arthritis risk
Annals of the Rheumatic Diseases, Vol. 74, Núm. 10, pp. 1875-1881
-
Association of the PDE3A-SLCO1C1 locus with the response to anti-TNF agents in psoriasis
Pharmacogenomics Journal, Vol. 15, Núm. 4, pp. 322-325